Pascal Soriot

Type: Person
Name: Pascal Soriot
First reported 1 hour ago - Updated 1 hour ago - 1 reports

No investigation of Brilinta

The United States Department of Justice has announced that it closes its investigation into PLATO clinical trial for AstraZeneca’s Brilinta.In the PLATO study, Brilinta (ticagrelor) was compared to clopidrogel combined with acetylsalicylic acid. The studied ... [Published Nordic Life Science - 1 hour ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe

AstraZeneca says the Department of Justice is ending its investigation into PLATO, a clinical trial with its heart drug Brilinta, and is not planning any further action. It began investigating the PLATO trial, which studied more than 18,000 patients in ... [Published TheStreet.com - 8 hours ago]
First reported Aug 19 2014 - Updated 15 hours ago - 3 reports

AstraZeneca Allowed to Market Heart Drug as Federal Probe Closed

AstraZeneca has won approval from the U.S. government to market its new heart drug Brilinta, following a federal probe. The company said the Department of Justice said it is closing its investigation into PLATO, a clinical trial with the drug, and is ... [Published TheStreet.com - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 5 reports

US Department of Justice closes investigation into AZ's PLATO clinical trial for Brilinta

19 Aug 14AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with Brilinta (ticagrelor). The government is not planning any further ... [Published PharmiWeb - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 19 2014 - 1 reports

AstraZeneca plc’s Dividends Are Sliding

AstraZeneca (LSE: AZN) (NYSE: AZN.US) has been providing investors with attractive dividend yields for years -- those blockbuster drugs do cost a lot of money to being to market, but once they've gained approval, they can be cash cows for years to co ... [Published Yahoo! UK and Ireland - Aug 18 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 1 reports

Pascal Soriot | AstraZeneca

At the time Pascal Soriot took over AstraZeneca, the pharma giant was in trouble as a number of its major product patents had expired. The CEO has revitalised the company by investing in R&DWhen Pascal Soriot took over AstraZeneca, the company’s profits ... [Published European CEO - Aug 04 2014]
First reported Jul 31 2014 - Updated Aug 01 2014 - 9 reports

AstraZeneca shows resilience

Ben Hirschler LondonASTRAZENECA raised its sales and earnings forecasts for the year yesterday, showing resilience after seeing off a $118 billion (R1 trillion) takeover approach from rival Pfizer two months ago.Second-quarter sales and earnings both ... [Published Daily News South Africa - Aug 01 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

AstraZeneca Group's (AZN) CEO Pascal Soriot on Q2 2014 Results - Earnings Call Transcript

Pascal SoriotGood afternoon, everybody. I'm Pascal Soriot and I'm joined today by Briggs Morrison, our EVP of Global Medicines Development and our Chief Medical Officer. I also have with me Marc Dunoyer, our CFO; Mene Pangalos, our EVP of Research & Early ... [Published Seeking Alpha - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 3 reports

AstraZeneca raises revenue expectations

Pharmaceutical giant AstraZeneca has raised its full-year guidance for 2014 and now expects to post revenue in line with last year – after previously expecting a slight fall.The group has raised its revenue expectations after posting a slight rise in ... [Published Insider Media Limited - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

BRIEF-Astra CEO says Nov. 18 investor day to focus on progress, no comment on Pfizer

AstraZeneca PLC CEO Pascal Soriottold reporters:* CEO says can't comment on Pfizer, says November 18 investorday will focus on company's progress * CEO says hopes for outcome to DOJ probe into Plato study on Brilinta verysoon * CEO says Almirall respiratory ... [Published Reuters - Jul 31 2014]
First reported Jul 30 2014 - Updated Jul 31 2014 - 5 reports

Astrazeneca restocks with Almirall asthma-drug deal

Britain's second biggest drugmaker, which fought off a £69billion takeover attempt by American heavyweight Pfizer in May, said it would pay an initial £514million and up to £717 million more if the drugs meet sales targets.It also signed a clinical trial ... [Published NewsRT.co.uk - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

City & Business MORNING MEETING: ITV figures to turn on investors

A healthy advertising outlook, improved cost savings, a greater presence on the international stage and the creative juices ?owing at its programme-making ITV Studios business, all help justify a trebling of the company’s market value over the past two ... [Published Daily Express - Jul 31 2014]

More Content

All (220) | News (188) | Reports (0) | Blogs (24) | Audio/Video (0) | Fact Sheets (0) | Press Releases (6)
sort by: Date | Relevance
No investigation of Brilinta [Published Nordic Life Science - 1 hour ago]
AstraZeneca Heart Drug Trial No Longer Subject ... [Published TheStreet.com - 8 hours ago]
Brilinta bill of health boosts AstraZeneca [Published PMLive - 13 hours ago]
AstraZeneca says Justice probe is over [Published Philly.com - Aug 19 2014]
U.S.ends probe of AstroZeneca's allegedly rigge... [Published CBS News - Aug 19 2014]
Why This Top Bio med Player Chose Cambridge [Published Noodls - Aug 19 2014]
AstraZeneca Allowed to Market Heart Drug as Fed... [Published TheStreet.com - Aug 19 2014]
US Department of Justice closes investigation i... [Published PharmiWeb - Aug 19 2014]
AstraZeneca : FTSE hits three week high with As... [Published 4 Traders - Aug 19 2014]
DoJ clears AstraZeneca for a U.S. Brilinta takeoff [Published FiercePharma - Aug 19 2014]
AZ gets all-clear in the USA over Brilinta data [Published Pharma Times - Aug 19 2014]
US DoJ closes investigation into AstraZeneca’s ... [Published Pharma Letter - Aug 19 2014]
AstraZeneca star heart drug cleared from concer... [Published Telegraph - Aug 19 2014]
US Department of Justice Closes Investigation i... [Published Wall Street Select - Aug 19 2014]
US Department of Justice Closes Investigation i... [Published Business Wire Health News - Aug 19 2014]
AstraZeneca’s battle boosted as US heart drug p... [Published London Evening Standard - Aug 19 2014]
UPDATE 2-U.S. clears AstraZeneca over heart dru... [Published Reuters - Aug 19 2014]
AstraZeneca plc’s Dividends Are Sliding [Published Interactive Investor - Aug 19 2014]
Reprieve for AstraZeneca as US drops drug inves... [Published Pharmafocus - Aug 19 2014]
AstraZeneca share price: US closes probe into B... [Published Invezz - Aug 19 2014]
AstraZeneca relief as US DoJ closes investigati... [Published London South East - Aug 19 2014]
AstraZeneca says US authorities end probe into ... [Published FirstWord Pharma - Aug 19 2014]
UPDATE 1-U.S. clears AstraZeneca over heart dru... [Published CNBC - Aug 19 2014]
ASTRAZENECA : US DOJ Closes Probe Into Plato Tr... [Published 4 Traders - Aug 19 2014]
AstraZeneca : Says US Probe Of Brilinta Trial E... [Published 4 Traders - Aug 19 2014]
AstraZeneca: DoJ Closes Its Investigation Of PL... [Published RTTNews.com - Aug 19 2014]
US DOJ Closes Investigation into Plato [Published GlobeNewswire: Acquisitions News - Aug 19 2014]
ASTRAZENECA : US DOJ Closes Investigation into ... [Published 4 Traders - Aug 19 2014]
AstraZeneca plc’s Dividends Are Sliding [Published Yahoo! UK and Ireland - Aug 18 2014]
Clash of the egos: When boardroom bust-ups dera... [Published Telegraph - Aug 09 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
US Department of Justice Closes Investigation i... [Published Business Wire Health News - Aug 19 2014]
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with BRILINTA® (ticagrelor) tablets. The government ...
AstraZeneca bolsters defences with strong sales [Published Proactiveinvestors United Kingdom website - Jul 31 2014]
AstraZeneca ( LON:AZN ) primed its defences against another assault from US pharma Pfizer by blasting past forecasts helped by a surge in sales of heart drug Brilinta. Sales rose by 4% to US$6.45bn (£3.8bn) in the three months to June  as  heart drug ...
"Not My Pay" says AZ's Soriot [Published The Big Red Biotech Blog - Jun 02 2014]
Fierce Pharma characterizes AZ's CEO Pascal Soriot as bristling to the idea that executive pay (including his own) should be tied to the sales forecast that he and board chairman Leif Johansson tossed out there as they tried to fend off Pfizer's takeover ...
Pfizer Decides AstraZeneca Isn’t Worth the Trou... [Published Wall St. Cheat Sheet - May 27 2014]
Source: Thinkstock After months of the chase, it seems Pfizer Inc.  ( NYSE:PFE ) has finally given up on its pursuit of British-Swedish drugmaker AstraZeneca Group Plc  ( NYSE:AZN ). The company announced in a statement on Monday that it would ...
Frontrunning: May 27 [Published Zero Hedge - May 27 2014]
Vietnam, China trade accusations after Vietnamese fishing boat sinks ( Reuters ) SEC Set to Spur Exchange Trading ( WSJ ) Bank of Japan quietly eyes stimulus exit ( Reuters ) Japan Risks Low Growth Even as Easing Spurs Inflation ( BBG ) Hello Japan: Bond ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
US DOJ Closes Investigation into Plato [Published GlobeNewswire: Acquisitions News - Aug 19 2014]
AstraZeneca agrees strategic transaction with A... [Published AstraZeneca - Jul 30 2014]
Director/PDMR Shareholding [Published GlobeNewswire: Acquisitions News - Jul 01 2014]
ASTRAZENECA UPDATES ON THE RAPID PROGRESS OF ON... [Published GlobeNewswire: Advertising News - Jun 03 2014]
ASTRAZENECA BOARD REJECTS PFIZER’S FINAL PROPOSAL [Published AstraZeneca - May 19 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.